Menu
Commercial License for CHOK1BN Commercial License for CHOK1BN

Commercial License for CHOK1BN

  • Adapted in Basic CD Medium
  • High Stability and Productivity
  • Suitable For Various Antibody Formats

Overview

Biointron's CHOK1BN cell line, sourced from ECACC and adapted explicitly for suspension culture in essential CD media, is valuable for antibody-related research. It is fully traceable from the original CHO cell line and can be sublicensed for commercial use. It's compliant with registration requirements in both China and the United States, making it a reliable and accessible choice for antibody development and production. In addition, the license is perpetual and irrevocable, only requiring a one-time sublicence fee.

Commercial License for CHOK1BN Overview

Highlights

Adapted in Basic CD Medium

  • Our cell line is suspension-adapted in basic CD medium
  • Adaptable to various other media formulations
  • Flexibility allows you to choose the most suitable medium for your specific antibody production needs

High Stability and Productivity

  • Antibody yields >10 g/L
  • The stability and productivity of CHOK1BN can simplify your biomanufacturing process, resulting in more efficient production.

Suitable For Various Antibody Formats

  • Our commercial license for CHOK1BN caters to a diverse range of applications
  • Formats include monoclonal antibodies, bispecific antibodies, factors, and more
  • This cell line's versatility enables you to explore a wide array of biologics
Speak to A Specialist

Licensing with Biointron

Biointron‘s CHOK1BN cell line is licensed from ECACC. (Contract No.BYC-SHSWZP211027)

  • Sublicense fee based on the project. Please contact us for more details.
  • The license is perpetual and irrevocable.
Licensing with Biointron

Deliverables

Delivery items
Host system
  • CHOK1BN cell line
Documentation
  • ECACC license order form, original invoice, COA, customs clearance report
  • Suspension-adapted report
  • Cell banking detection report (including sterility test, mycoplasma test, in vitro assay for the detection of viral contaminants, etc.)
  • COA of FBS and Trpsin
Protocols
  • Cell culture protocol
  • Cell line development protocol (including transfection, cell pool screening and cell clone screening)

FAQs

  • What is a CHOK1BN cell line sublicence?

    A CHOK1BN cell line sublicense is a legal agreement that allows a third party (the sublicensee) to use the CHOK1BN cell line, which is owned by another entity (the licensor), for purposes such as research, development, or commercial reasons.

    Sublicensing allows the original licensor to expand the reach and potential applications of their cell line technology while providing the sublicensee with access to valuable research tools or resources. It is a common practice in the biotechnology and pharmaceutical industries, where cell lines are frequently used as essential tools in various scientific endeavors and therapeutic development.

  • What applications use a cell line sublicence?

    There are numerous applications for the use of the CHOK1BN cell line sublicense, including drug discovery and development, biomanufacturing, diagnostic development, genetic engineering, viral vector production, and in vitro disease modeling.

  • What are CHO cells?

    Chinese hamster ovary (CHO) cell lines are derived from the ovary of adult, female Chinese hamsters. CHO cells were first established in 1957 by T. Puck, and were subsequently multiplied and optimized in vitro, allowing it to be cultured indefinitely. The CHO-K1 cell line was derived as a subclone from that parental CHO cell line. They are typically the preferred host expression system for recombinant antibodies due to their advantages in producing complex therapeutics and manufacturing adaptability.1

Resources

References

  • Gamper, N., Stockand, J. D., & Shapiro, M. S. (2005). The use of Chinese hamster ovary (CHO) cells in the study of ion channels. Journal of pharmacological and toxicological methods, 51 (3), 177–185. https://doi.org/10.1016/j.vascn.2004.08.008

Services & Products

HTP Recombinant
Antibody Production
Bispecific Antibody
Production
Large Scale Antibody
Production
Protein Expression In
Mammalian system
Single B Cell Screening
(Antibody Discovery)
CHO-K1 Stable
Cell line Generation
VHH Antibody
Discovery
Antibody
Humanization
Affinity
Maturation
View All

If you don’t find what you need, let us know with a message.

We'll respond as soon as possible to assist you!

*
*
*
*
*
*
*
testi-1

You can also contact us on the Scientist and Science Exchange marketplaces.

scientist science

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.